Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 1,198

The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.

Protein Kinase Inhibitors: Insights into Drug Design from Structure

Open access
Noble, Martin E. M., Endicott, Jane A., Johnson, Louise N. · 2004 · Science

Abstract

Protein kinases are targets for treatment of a number of diseases. This review focuses on kinase inhibitors that are in the clinic or in clinical trials and for which structural information is available. Structures have informed drug design and have illuminated the mechanism of inhibition. We review progress with the receptor tyrosine kinases (growth factor receptors EGFR, VEGFR, and FGFR) and nonreceptor tyrosine kinases (Bcr-Abl), where advances have been made with cancer therapeutic agents such as Herceptin and Gleevec. Among the serine-threonine kinases, p38, Rho-kinase, cyclin-dependent kinases, and Chk1 have been targeted with productive results for inflammation and cancer. Structures have provided insights into targeting the inactive or active form of the kinase, for targeting the global constellation of residues at the ATP site or less conserved additional pockets or single residues, and into targeting noncatalytic domains.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/science.1095920

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 9

  1. D. J. Pratt J. A. Endicott M. E. Noble Curr. Opin. Drug Discov. Dev. in press.
  2. J. Baselga, L. A. Hammond, Oncology63, (Suppl. 1), 6 (2002).
  3. F. J. Giles, Oncology (Huntington)16, 23 (2002).
  4. 10.1007/s11864-001-0070-0 · doi:10.1007/s11864-001-0070-0
  5. 10.1345/aph.1A162 · doi:10.1345/aph.1a162 · Paper page
  6. G. Shapiroet al., Proc. Am. Soc. Clin. Oncol.22, 199 (2003).
  7. 10.1021/ar0201198 · doi:10.1021/ar0201198
  8. B. Nagaret al., Cancer Res.62, 4236 (2002).
  9. 10.1016/j.str.2003.09.020 · doi:10.1016/j.str.2003.09.020

Cited by

See all 1,198

Metadata

Authors
Noble, M. E. M., Endicott, J. A., & Johnson, L. N.
Venue
Science
Published
2004-03-19
Volume
303
Issue
5665
Pages
1800-1805
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W2138072853
Cited by
1,198
References
67
FWCI
30.40
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.